Alle Storys
Folgen
Keine Story von antwerpes AG mehr verpassen.

antwerpes AG

euro adhoc: DocCheck AG
other
DocCheck AG calls in 260,860 of its own shares

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
19.02.2008
Cologne, 19 February 2008 - Today the Board of Directors of DocCheck 
AG (ISIN DE0005471007) with its registered office in Cologne has, 
with the approval of the Supervisory Board granted today, decided to 
call in 260,860 of its own shares with an arithmetical share in the 
capital stock of EUR 1.00 per share. This corresponds to 4.42 per 
cent of the capital stock. At the same time the capital stock of 
DocCheck AG which currently stands at EUR 5,904,312.00 is reduced by 
EUR 260,860.00, taking it down to EUR 5,643,452.00. After calling in 
the shares, DocCheck AG still has 427 of its own shares (position as 
at 19-02-2008). The current share buy-back programme continues.
end of announcement                               euro adhoc

Further inquiry note:

DocCheck AG
Tanja Mumme
Corporate Communications
Vogelsanger Str. 66
D-50823 Cologne
Tel.: +49 221 92053 139
Fax: +49 221 92053 133
eMail: ir@doccheck.com

Branche: Computing & Information Technology
ISIN: DE0005471007
WKN: 547100
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade

Weitere Storys: antwerpes AG
Weitere Storys: antwerpes AG